PRF1 and neoplasm: EVs derived from NK cells exert tumor cell killing and inhibitory functions through four main mechanisms, including Fas/Fas ligand (FasL) pathway, perforin/granzyme pathway, tumor necrosis factor (TNF)-α pathway, and miRNA-mediated targeted regulation pathways (Figure 4).